Search Browse Earnings

ANAVEX LIFE SCIENCES CORP.

Nasdaq:AVXL

Biological Products, (No Diagnostic Substances)·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Missling Christopher U

Revenue

—

Adj. EBITDA

-$55.8M

FY 2025

Net Income

-$47.5M

FY 2025

EPS (Diluted)

-$0.60

FY 2025

Stock Price

$4.75

+2.0%

2026-03-10

52W Range

$2.86 – $13.99

P/E Ratio

-7.9x

Market Cap

$439.7M

Cash

$132.2M

FY 2025

Total Debt

$85,570

FY 2016

Net Cash

$132.1M

FY 2016

Enterprise Value

$307.6M

Debt / EBITDA

2.4x

FY 2025

EV / EBITDA

-5.5x

Employees

—